{
    "code": "02022870",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02022870",
    "time": "2021-06-04 03:10:34",
    "許可證字號": "衛署藥輸字第022870號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "114\/05\/02",
    "發證日期": "89\/05\/02",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202287003",
    "中文品名": "濟而剛　口服液",
    "英文品名": "ZIAGEN ORAL SOLUTION",
    "適應症": "用於抗反轉錄病毒組合療法，以治療成人及兒童之人類免疫缺乏病毒（ＨＩＶ）感染。",
    "劑型": "170內服液劑",
    "包裝": "塑膠瓶裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "ABACAVIR SULFATE",
    "限制項目": "02輸　入",
    "申請商名稱": "1115901100  荷商葛蘭素史克藥廠股份有限公司台灣分公司",
    "申請商地址": "台北市中正區忠孝西路一段66號23-24樓",
    "主製造廠": [
        {
            "製造廠名稱": "FCA0037000  BORA PHARMACEUTICAL SERVICES INC.",
            "製造廠廠址": "7333 MISSISSAUGA ROAD, MISSISSAUGA, ONTARIO CANADA, L5N 6L4",
            "製造廠公司地址": "",
            "製造廠國別": "CANADA",
            "製程": ""
        }
    ],
    "CCC號列": "30049072004 抗人類免疫缺乏病毒感染用藥Drugs for anti human immunodeficiency virus (HIV) infections",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "0818001610",
            "成分名稱": "ABACAVIR SULFATE",
            "含量描述": "",
            "含量": "23.4000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "02022870_Ziagen OS IPI07-final-107-06-05(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022870&Seq=001&Type=9"
        }
    ]
}